Global Large Molecule Drug Substance CDMO Market Size study, By Services (Contract Manufacturing, Contract Development), By Source (Mammalian, Microbial, Others), By End-user (Biotech Companies, CRO, Others), and Regional Forecasts 2022-2028
Global Large Molecule Drug Substance CDMO Market is valued at approximately USD 10.7 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 8.6% over the forecast period 2022-2028. Large-molecule drugs are known as biologics or biopharmaceuticals are sophisticated therapeutics that are thousands of times larger in molecular size compared to their chemically-synthesized counterparts. A contract development and manufacturing company (CDMO) is a company across the pharmaceutical sector that offers manufacturing services and drug development. Various pharmaceutical companies collaborate with CDMOs as a way to outsource drug development and drug manufacturing. The growing prevalence of various infectious diseases, surging demand for novel therapeutics, as well as rising number of strategic initiatives by the market players like investment, product launch, and many others are bolstering the market demand across the globe. For instance, in June 2020, FUJIFILM Corp. intended to invest nearly USD 778 billion for their FUJIFILM Diosynth Biotechnologies’ Denmark site, CDMO for advanced therapies and biologics. This investment supports Denmark's site’s existing drug substance manufacturing capability by double fold. Consequentially, growing initiatives by the market players are augmenting the market growth in the near future. However, several compliance issues are associated with outsourcing, and the imposition of regulatory and legal compliance impedes the growth of the market over the forecast period of 2022-2028. Also, the increasing research and development investments and growth of the biopharmaceutical sector are anticipated to act as catalyzing factors for the market demand during the forecast period.
The key regions considered for the global Large Molecule Drug Substance CDMO Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the heavy R&D investments, and the presence of various prominent market players. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as availability of a low-cost and skilled workforce as well as presence of favorable regulatory scenario would create lucrative growth prospects for the Large Molecule Drug Substance CDMO Market across the Asia-Pacific region.
Major market players included in this report are:
Eurofins Scientific
WuXi Biologics
Samsung Biologics
Catalent, Inc.
Cambrex Corp.
AGC Biologics
Recipharm AB (publ)
Siegfried Holding AG
LabCorp Drug Development
FUJIFILM Diosynth Biotechnologies
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Services:
Contract Manufacturing
Contract Development
By Source:
Mammalian
Microbial
Others
By End-user:
Biotech Companies
CRO
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028
Target Audience of the Global Large Molecule Drug Substance CDMO Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
The key regions considered for the global Large Molecule Drug Substance CDMO Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the heavy R&D investments, and the presence of various prominent market players. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as availability of a low-cost and skilled workforce as well as presence of favorable regulatory scenario would create lucrative growth prospects for the Large Molecule Drug Substance CDMO Market across the Asia-Pacific region.
Major market players included in this report are:
Eurofins Scientific
WuXi Biologics
Samsung Biologics
Catalent, Inc.
Cambrex Corp.
AGC Biologics
Recipharm AB (publ)
Siegfried Holding AG
LabCorp Drug Development
FUJIFILM Diosynth Biotechnologies
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Services:
Contract Manufacturing
Contract Development
By Source:
Mammalian
Microbial
Others
By End-user:
Biotech Companies
CRO
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028
Target Audience of the Global Large Molecule Drug Substance CDMO Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Large Molecule Drug Substance CDMO Market, by Region, 2020-2028 (USD Billion)
1.2.2. Large Molecule Drug Substance CDMO Market, by Services, 2020-2028 (USD Billion)
1.2.3. Large Molecule Drug Substance CDMO Market, by Source, 2020-2028 (USD Billion)
1.2.4. Large Molecule Drug Substance CDMO Market, by End-user, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL LARGE MOLECULE DRUG SUBSTANCE CDMO MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL LARGE MOLECULE DRUG SUBSTANCE CDMO MARKET DYNAMICS
3.1. Large Molecule Drug Substance CDMO Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Growing prevalence of various infectious diseases
3.1.1.2. Surging demand for novel therapeutics
3.1.2. Market Challenges
3.1.2.1. Several compliance issues are associated with outsourcing
3.1.2.2. Imposition of regulatory and legal compliance
3.1.3. Market Opportunities
3.1.3.1. Increasing research and development investments
3.1.3.2. Growth of the biopharmaceutical sector
CHAPTER 4. GLOBAL LARGE MOLECULE DRUG SUBSTANCE CDMO MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
CHAPTER 6. GLOBAL LARGE MOLECULE DRUG SUBSTANCE CDMO MARKET, BY SERVICES
6.1. Market Snapshot
6.2. Global Large Molecule Drug Substance CDMO Market by Services, Performance - Potential Analysis
6.3. Global Large Molecule Drug Substance CDMO Market Estimates & Forecasts by Services, 2018-2028 (USD Billion)
6.4. Large Molecule Drug Substance CDMO Market, Sub Segment Analysis
6.4.1. Contract Manufacturing
6.4.2. Contract Development
CHAPTER 7. GLOBAL LARGE MOLECULE DRUG SUBSTANCE CDMO MARKET, BY SOURCE
7.1. Market Snapshot
7.2. Global Large Molecule Drug Substance CDMO Market by Source, Performance – Potential Analysis
7.3. Global Large Molecule Drug Substance CDMO Market Estimates & Forecasts by Source, 2018-2028 (USD Billion)
7.4. Large Molecule Drug Substance CDMO Market, Sub Segment Analysis
7.4.1. Mammalian
7.4.2. Microbial
7.4.3. Others
CHAPTER 8. GLOBAL LARGE MOLECULE DRUG SUBSTANCE CDMO MARKET, BY END-USER
8.1. Market Snapshot
8.2. Global Large Molecule Drug Substance CDMO Market by End-user, Performance - Potential Analysis
8.3. Global Large Molecule Drug Substance CDMO Market Estimates & Forecasts by End-user 2018-2028 (USD Billion)
8.4. Large Molecule Drug Substance CDMO Market, Sub Segment Analysis
8.4.1. Biotech Companies
8.4.2. CRO
8.4.3. Others
CHAPTER 9. GLOBAL LARGE MOLECULE DRUG SUBSTANCE CDMO MARKET, REGIONAL ANALYSIS
9.1. Large Molecule Drug Substance CDMO Market, Regional Market Snapshot
9.2. North America Large Molecule Drug Substance CDMO Market
9.2.1. U.S. Large Molecule Drug Substance CDMO Market
9.2.1.1. Services breakdown estimates & forecasts, 2018-2028
9.2.1.2. Source breakdown estimates & forecasts, 2018-2028
9.2.1.3. End-user breakdown estimates & forecasts, 2018-2028
9.2.2. Canada Large Molecule Drug Substance CDMO Market
9.3. Europe Large Molecule Drug Substance CDMO Market Snapshot
9.3.1. U.K. Large Molecule Drug Substance CDMO Market
9.3.2. Germany Large Molecule Drug Substance CDMO Market
9.3.3. France Large Molecule Drug Substance CDMO Market
9.3.4. Spain Large Molecule Drug Substance CDMO Market
9.3.5. Italy Large Molecule Drug Substance CDMO Market
9.3.6. Rest of Europe Large Molecule Drug Substance CDMO Market
9.4. Asia-Pacific Large Molecule Drug Substance CDMO Market Snapshot
9.4.1. China Large Molecule Drug Substance CDMO Market
9.4.2. India Large Molecule Drug Substance CDMO Market
9.4.3. Japan Large Molecule Drug Substance CDMO Market
9.4.4. Australia Large Molecule Drug Substance CDMO Market
9.4.5. South Korea Large Molecule Drug Substance CDMO Market
9.4.6. Rest of Asia Pacific Large Molecule Drug Substance CDMO Market
9.5. Latin America Large Molecule Drug Substance CDMO Market Snapshot
9.5.1. Brazil Large Molecule Drug Substance CDMO Market
9.5.2. Mexico Large Molecule Drug Substance CDMO Market
9.6. Rest of The World Large Molecule Drug Substance CDMO Market
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Eurofins Scientific
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. WuXi Biologics
10.2.3. Samsung Biologics
10.2.4. Catalent, Inc.
10.2.5. Cambrex Corp.
10.2.6. AGC Biologics
10.2.7. Recipharm AB (publ)
10.2.8. Siegfried Holding AG
10.2.9. LabCorp Drug Development
10.2.10. FUJIFILM Diosynth Biotechnologies
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Large Molecule Drug Substance CDMO Market, by Region, 2020-2028 (USD Billion)
1.2.2. Large Molecule Drug Substance CDMO Market, by Services, 2020-2028 (USD Billion)
1.2.3. Large Molecule Drug Substance CDMO Market, by Source, 2020-2028 (USD Billion)
1.2.4. Large Molecule Drug Substance CDMO Market, by End-user, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL LARGE MOLECULE DRUG SUBSTANCE CDMO MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL LARGE MOLECULE DRUG SUBSTANCE CDMO MARKET DYNAMICS
3.1. Large Molecule Drug Substance CDMO Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Growing prevalence of various infectious diseases
3.1.1.2. Surging demand for novel therapeutics
3.1.2. Market Challenges
3.1.2.1. Several compliance issues are associated with outsourcing
3.1.2.2. Imposition of regulatory and legal compliance
3.1.3. Market Opportunities
3.1.3.1. Increasing research and development investments
3.1.3.2. Growth of the biopharmaceutical sector
CHAPTER 4. GLOBAL LARGE MOLECULE DRUG SUBSTANCE CDMO MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
CHAPTER 6. GLOBAL LARGE MOLECULE DRUG SUBSTANCE CDMO MARKET, BY SERVICES
6.1. Market Snapshot
6.2. Global Large Molecule Drug Substance CDMO Market by Services, Performance - Potential Analysis
6.3. Global Large Molecule Drug Substance CDMO Market Estimates & Forecasts by Services, 2018-2028 (USD Billion)
6.4. Large Molecule Drug Substance CDMO Market, Sub Segment Analysis
6.4.1. Contract Manufacturing
6.4.2. Contract Development
CHAPTER 7. GLOBAL LARGE MOLECULE DRUG SUBSTANCE CDMO MARKET, BY SOURCE
7.1. Market Snapshot
7.2. Global Large Molecule Drug Substance CDMO Market by Source, Performance – Potential Analysis
7.3. Global Large Molecule Drug Substance CDMO Market Estimates & Forecasts by Source, 2018-2028 (USD Billion)
7.4. Large Molecule Drug Substance CDMO Market, Sub Segment Analysis
7.4.1. Mammalian
7.4.2. Microbial
7.4.3. Others
CHAPTER 8. GLOBAL LARGE MOLECULE DRUG SUBSTANCE CDMO MARKET, BY END-USER
8.1. Market Snapshot
8.2. Global Large Molecule Drug Substance CDMO Market by End-user, Performance - Potential Analysis
8.3. Global Large Molecule Drug Substance CDMO Market Estimates & Forecasts by End-user 2018-2028 (USD Billion)
8.4. Large Molecule Drug Substance CDMO Market, Sub Segment Analysis
8.4.1. Biotech Companies
8.4.2. CRO
8.4.3. Others
CHAPTER 9. GLOBAL LARGE MOLECULE DRUG SUBSTANCE CDMO MARKET, REGIONAL ANALYSIS
9.1. Large Molecule Drug Substance CDMO Market, Regional Market Snapshot
9.2. North America Large Molecule Drug Substance CDMO Market
9.2.1. U.S. Large Molecule Drug Substance CDMO Market
9.2.1.1. Services breakdown estimates & forecasts, 2018-2028
9.2.1.2. Source breakdown estimates & forecasts, 2018-2028
9.2.1.3. End-user breakdown estimates & forecasts, 2018-2028
9.2.2. Canada Large Molecule Drug Substance CDMO Market
9.3. Europe Large Molecule Drug Substance CDMO Market Snapshot
9.3.1. U.K. Large Molecule Drug Substance CDMO Market
9.3.2. Germany Large Molecule Drug Substance CDMO Market
9.3.3. France Large Molecule Drug Substance CDMO Market
9.3.4. Spain Large Molecule Drug Substance CDMO Market
9.3.5. Italy Large Molecule Drug Substance CDMO Market
9.3.6. Rest of Europe Large Molecule Drug Substance CDMO Market
9.4. Asia-Pacific Large Molecule Drug Substance CDMO Market Snapshot
9.4.1. China Large Molecule Drug Substance CDMO Market
9.4.2. India Large Molecule Drug Substance CDMO Market
9.4.3. Japan Large Molecule Drug Substance CDMO Market
9.4.4. Australia Large Molecule Drug Substance CDMO Market
9.4.5. South Korea Large Molecule Drug Substance CDMO Market
9.4.6. Rest of Asia Pacific Large Molecule Drug Substance CDMO Market
9.5. Latin America Large Molecule Drug Substance CDMO Market Snapshot
9.5.1. Brazil Large Molecule Drug Substance CDMO Market
9.5.2. Mexico Large Molecule Drug Substance CDMO Market
9.6. Rest of The World Large Molecule Drug Substance CDMO Market
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Eurofins Scientific
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. WuXi Biologics
10.2.3. Samsung Biologics
10.2.4. Catalent, Inc.
10.2.5. Cambrex Corp.
10.2.6. AGC Biologics
10.2.7. Recipharm AB (publ)
10.2.8. Siegfried Holding AG
10.2.9. LabCorp Drug Development
10.2.10. FUJIFILM Diosynth Biotechnologies
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Large Molecule Drug Substance CDMO Market, report scope
TABLE 2. Global Large Molecule Drug Substance CDMO Market estimates & forecasts by Region 2018-2028 (USD Billion)
TABLE 3. Global Large Molecule Drug Substance CDMO Market estimates & forecasts by Services 2018-2028 (USD Billion)
TABLE 4. Global Large Molecule Drug Substance CDMO Market estimates & forecasts by Source 2018-2028 (USD Billion)
TABLE 5. Global Large Molecule Drug Substance CDMO Market estimates & forecasts by End-user 2018-2028 (USD Billion)
TABLE 6. Global Large Molecule Drug Substance CDMO Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 7. Global Large Molecule Drug Substance CDMO Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 8. Global Large Molecule Drug Substance CDMO Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 9. Global Large Molecule Drug Substance CDMO Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 10. Global Large Molecule Drug Substance CDMO Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 11. Global Large Molecule Drug Substance CDMO Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 12. Global Large Molecule Drug Substance CDMO Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 13. Global Large Molecule Drug Substance CDMO Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 14. Global Large Molecule Drug Substance CDMO Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 15. Global Large Molecule Drug Substance CDMO Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 16. U.S. Large Molecule Drug Substance CDMO Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 17. U.S. Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 18. U.S. Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 19. Canada Large Molecule Drug Substance CDMO Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 20. Canada Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 21. Canada Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 22. UK Large Molecule Drug Substance CDMO Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 23. UK Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 24. UK Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 25. Germany Large Molecule Drug Substance CDMO Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 26. Germany Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 27. Germany Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 28. RoE Large Molecule Drug Substance CDMO Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 29. RoE Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 30. RoE Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 31. China Large Molecule Drug Substance CDMO Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 32. China Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 33. China Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 34. India Large Molecule Drug Substance CDMO Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 35. India Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 36. India Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 37. Japan Large Molecule Drug Substance CDMO Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 38. Japan Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 39. Japan Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 40. RoAPAC Large Molecule Drug Substance CDMO Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 41. RoAPAC Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 42. RoAPAC Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 43. Brazil Large Molecule Drug Substance CDMO Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 44. Brazil Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 45. Brazil Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 46. Mexico Large Molecule Drug Substance CDMO Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 47. Mexico Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 48. Mexico Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 49. RoLA Large Molecule Drug Substance CDMO Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 50. RoLA Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 51. RoLA Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 52. Row Large Molecule Drug Substance CDMO Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 53. Row Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 54. Row Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 55. List of secondary sources, used in the study of global Large Molecule Drug Substance CDMO Market
TABLE 56. List of primary sources, used in the study of global Large Molecule Drug Substance CDMO Market
TABLE 57. Years considered for the study
TABLE 58. Exchange rates considered
TABLE 1. Global Large Molecule Drug Substance CDMO Market, report scope
TABLE 2. Global Large Molecule Drug Substance CDMO Market estimates & forecasts by Region 2018-2028 (USD Billion)
TABLE 3. Global Large Molecule Drug Substance CDMO Market estimates & forecasts by Services 2018-2028 (USD Billion)
TABLE 4. Global Large Molecule Drug Substance CDMO Market estimates & forecasts by Source 2018-2028 (USD Billion)
TABLE 5. Global Large Molecule Drug Substance CDMO Market estimates & forecasts by End-user 2018-2028 (USD Billion)
TABLE 6. Global Large Molecule Drug Substance CDMO Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 7. Global Large Molecule Drug Substance CDMO Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 8. Global Large Molecule Drug Substance CDMO Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 9. Global Large Molecule Drug Substance CDMO Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 10. Global Large Molecule Drug Substance CDMO Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 11. Global Large Molecule Drug Substance CDMO Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 12. Global Large Molecule Drug Substance CDMO Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 13. Global Large Molecule Drug Substance CDMO Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 14. Global Large Molecule Drug Substance CDMO Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 15. Global Large Molecule Drug Substance CDMO Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 16. U.S. Large Molecule Drug Substance CDMO Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 17. U.S. Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 18. U.S. Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 19. Canada Large Molecule Drug Substance CDMO Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 20. Canada Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 21. Canada Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 22. UK Large Molecule Drug Substance CDMO Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 23. UK Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 24. UK Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 25. Germany Large Molecule Drug Substance CDMO Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 26. Germany Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 27. Germany Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 28. RoE Large Molecule Drug Substance CDMO Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 29. RoE Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 30. RoE Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 31. China Large Molecule Drug Substance CDMO Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 32. China Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 33. China Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 34. India Large Molecule Drug Substance CDMO Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 35. India Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 36. India Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 37. Japan Large Molecule Drug Substance CDMO Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 38. Japan Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 39. Japan Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 40. RoAPAC Large Molecule Drug Substance CDMO Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 41. RoAPAC Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 42. RoAPAC Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 43. Brazil Large Molecule Drug Substance CDMO Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 44. Brazil Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 45. Brazil Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 46. Mexico Large Molecule Drug Substance CDMO Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 47. Mexico Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 48. Mexico Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 49. RoLA Large Molecule Drug Substance CDMO Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 50. RoLA Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 51. RoLA Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 52. Row Large Molecule Drug Substance CDMO Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 53. Row Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 54. Row Large Molecule Drug Substance CDMO Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 55. List of secondary sources, used in the study of global Large Molecule Drug Substance CDMO Market
TABLE 56. List of primary sources, used in the study of global Large Molecule Drug Substance CDMO Market
TABLE 57. Years considered for the study
TABLE 58. Exchange rates considered
LIST OF FIGURES
FIG 1. Global Large Molecule Drug Substance CDMO Market, research methodology
FIG 2. Global Large Molecule Drug Substance CDMO Market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Large Molecule Drug Substance CDMO Market, key trends 2021
FIG 5. Global Large Molecule Drug Substance CDMO Market, growth prospects 2022-2028
FIG 6. Global Large Molecule Drug Substance CDMO Market, porters 5 force model
FIG 7. Global Large Molecule Drug Substance CDMO Market, pest analysis
FIG 8. Global Large Molecule Drug Substance CDMO Market, value chain analysis
FIG 9. Global Large Molecule Drug Substance CDMO Market by segment, 2018 & 2028 (USD Billion)
FIG 10. Global Large Molecule Drug Substance CDMO Market by segment, 2018 & 2028 (USD Billion)
FIG 11. Global Large Molecule Drug Substance CDMO Market by segment, 2018 & 2028 (USD Billion)
FIG 12. Global Large Molecule Drug Substance CDMO Market by segment, 2018 & 2028 (USD Billion)
FIG 13. Global Large Molecule Drug Substance CDMO Market by segment, 2018 & 2028 (USD Billion)
FIG 14. Global Large Molecule Drug Substance CDMO Market, regional snapshot 2018 & 2028
FIG 15. North America Large Molecule Drug Substance CDMO Market 2018 & 2028 (USD Billion)
FIG 16. Europe Large Molecule Drug Substance CDMO Market 2018 & 2028 (USD Billion)
FIG 17. Asia Pacific Large Molecule Drug Substance CDMO market 2018 & 2028 (USD Billion)
FIG 18. Latin America Large Molecule Drug Substance CDMO Market 2018 & 2028 (USD Billion)
FIG 19. Global Large Molecule Drug Substance CDMO Market, company market share analysis (2021)
FIG 1. Global Large Molecule Drug Substance CDMO Market, research methodology
FIG 2. Global Large Molecule Drug Substance CDMO Market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Large Molecule Drug Substance CDMO Market, key trends 2021
FIG 5. Global Large Molecule Drug Substance CDMO Market, growth prospects 2022-2028
FIG 6. Global Large Molecule Drug Substance CDMO Market, porters 5 force model
FIG 7. Global Large Molecule Drug Substance CDMO Market, pest analysis
FIG 8. Global Large Molecule Drug Substance CDMO Market, value chain analysis
FIG 9. Global Large Molecule Drug Substance CDMO Market by segment, 2018 & 2028 (USD Billion)
FIG 10. Global Large Molecule Drug Substance CDMO Market by segment, 2018 & 2028 (USD Billion)
FIG 11. Global Large Molecule Drug Substance CDMO Market by segment, 2018 & 2028 (USD Billion)
FIG 12. Global Large Molecule Drug Substance CDMO Market by segment, 2018 & 2028 (USD Billion)
FIG 13. Global Large Molecule Drug Substance CDMO Market by segment, 2018 & 2028 (USD Billion)
FIG 14. Global Large Molecule Drug Substance CDMO Market, regional snapshot 2018 & 2028
FIG 15. North America Large Molecule Drug Substance CDMO Market 2018 & 2028 (USD Billion)
FIG 16. Europe Large Molecule Drug Substance CDMO Market 2018 & 2028 (USD Billion)
FIG 17. Asia Pacific Large Molecule Drug Substance CDMO market 2018 & 2028 (USD Billion)
FIG 18. Latin America Large Molecule Drug Substance CDMO Market 2018 & 2028 (USD Billion)
FIG 19. Global Large Molecule Drug Substance CDMO Market, company market share analysis (2021)
